logo

A S U

Affects 2% globally

2021-09-14

Faculty of Medicine and Boehringer Ingelheim launch an advanced training program to diagnose and treat cardiomyopathy

Faculty of Medicine, Ain Shams University, launched a new program with participation of Boehringer Ingelheim to train doctors in the diagnosis, treatment and follow-up of cardiomyopathy, which affects 2% globally and causes the death of 50% of diagnosed within five years

Read More